Cargando…
Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease
Effectively improving myocardial blood flow and controlling atherosclerotic plaque have always been key and difficult points in the prevention and treatment of coronary artery disease (CAD). Although “therapeutic angiogenesis” is regarded as a promising approach for ischemic heart disease by improvi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110048/ https://www.ncbi.nlm.nih.gov/pubmed/30186354 http://dx.doi.org/10.1155/2018/3725962 |
_version_ | 1783350412612468736 |
---|---|
author | Yuan, Rong Shi, Wei-Li Xin, Qi-Qi Chen, Ke-Ji Cong, Wei-Hong |
author_facet | Yuan, Rong Shi, Wei-Li Xin, Qi-Qi Chen, Ke-Ji Cong, Wei-Hong |
author_sort | Yuan, Rong |
collection | PubMed |
description | Effectively improving myocardial blood flow and controlling atherosclerotic plaque have always been key and difficult points in the prevention and treatment of coronary artery disease (CAD). Although “therapeutic angiogenesis” is regarded as a promising approach for ischemic heart disease by improving blood flow, angiogenesis itself can induce the destabilization of atherosclerotic plaque, which reflects the double-edged role of angiogenesis. Modulating the balance of angiogenesis can be an important target for CAD treatment. Traditional Chinese medicine (TCM) emphasizes the holistic view and dynamic balance of the body. Furthermore, the principle of activating blood circulation and removing blood stasis (ABCRS) is closely connected with angiogenesis and CAD. Recent research suggests that Chinese herbal medicines for ABCRS are effective in balancing the regulation of angiogenesis. This review presents the progress of recent research on the angiogenesis regulation with Chinese herbal medicines for ABCRS in CAD. Moreover, this review demonstrates that Chinese herbal medicines for ABCRS can not only promote angiogenesis in the ischemic area to improve myocardial blood flow but also alleviate angiogenesis to stabilize plaque in atherosclerosis, which reflects the holistic regulatory role in CAD treatment. |
format | Online Article Text |
id | pubmed-6110048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-61100482018-09-05 Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease Yuan, Rong Shi, Wei-Li Xin, Qi-Qi Chen, Ke-Ji Cong, Wei-Hong Evid Based Complement Alternat Med Review Article Effectively improving myocardial blood flow and controlling atherosclerotic plaque have always been key and difficult points in the prevention and treatment of coronary artery disease (CAD). Although “therapeutic angiogenesis” is regarded as a promising approach for ischemic heart disease by improving blood flow, angiogenesis itself can induce the destabilization of atherosclerotic plaque, which reflects the double-edged role of angiogenesis. Modulating the balance of angiogenesis can be an important target for CAD treatment. Traditional Chinese medicine (TCM) emphasizes the holistic view and dynamic balance of the body. Furthermore, the principle of activating blood circulation and removing blood stasis (ABCRS) is closely connected with angiogenesis and CAD. Recent research suggests that Chinese herbal medicines for ABCRS are effective in balancing the regulation of angiogenesis. This review presents the progress of recent research on the angiogenesis regulation with Chinese herbal medicines for ABCRS in CAD. Moreover, this review demonstrates that Chinese herbal medicines for ABCRS can not only promote angiogenesis in the ischemic area to improve myocardial blood flow but also alleviate angiogenesis to stabilize plaque in atherosclerosis, which reflects the holistic regulatory role in CAD treatment. Hindawi 2018-08-13 /pmc/articles/PMC6110048/ /pubmed/30186354 http://dx.doi.org/10.1155/2018/3725962 Text en Copyright © 2018 Rong Yuan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Yuan, Rong Shi, Wei-Li Xin, Qi-Qi Chen, Ke-Ji Cong, Wei-Hong Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title_full | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title_fullStr | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title_full_unstemmed | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title_short | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
title_sort | holistic regulation of angiogenesis with chinese herbal medicines as a new option for coronary artery disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110048/ https://www.ncbi.nlm.nih.gov/pubmed/30186354 http://dx.doi.org/10.1155/2018/3725962 |
work_keys_str_mv | AT yuanrong holisticregulationofangiogenesiswithchineseherbalmedicinesasanewoptionforcoronaryarterydisease AT shiweili holisticregulationofangiogenesiswithchineseherbalmedicinesasanewoptionforcoronaryarterydisease AT xinqiqi holisticregulationofangiogenesiswithchineseherbalmedicinesasanewoptionforcoronaryarterydisease AT chenkeji holisticregulationofangiogenesiswithchineseherbalmedicinesasanewoptionforcoronaryarterydisease AT congweihong holisticregulationofangiogenesiswithchineseherbalmedicinesasanewoptionforcoronaryarterydisease |